- Home
- CTXR vs CLDI Comparison
CTXR vs CLDI Comparison
Compare CTXR & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTXR
- CLDI
- Stock Information
- Founded
- CTXR 2007
- CLDI 2014
- Country
- CTXR United States
- CLDI United States
- Employees
- CTXR N/A
- CLDI N/A
- Industry
- CTXR Biotechnology: Pharmaceutical Preparations
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CTXR Health Care
- CLDI Health Care
- Exchange
- CTXR Nasdaq
- CLDI Nasdaq
- Market Cap
- CTXR 14.6M
- CLDI 14.0M
- IPO Year
- CTXR N/A
- CLDI N/A
- Fundamental
- Price
- CTXR $0.84
- CLDI $0.48
- Analyst Decision
- CTXR Strong Buy
- CLDI Strong Buy
- Analyst Count
- CTXR 2
- CLDI 2
- Target Price
- CTXR $54.50
- CLDI $15.00
- AVG Volume (30 Days)
- CTXR 679.0K
- CLDI 386.9K
- Earning Date
- CTXR 05-13-2025
- CLDI 05-13-2025
- Dividend Yield
- CTXR N/A
- CLDI N/A
- EPS Growth
- CTXR N/A
- CLDI N/A
- EPS
- CTXR N/A
- CLDI N/A
- Revenue
- CTXR N/A
- CLDI N/A
- Revenue This Year
- CTXR N/A
- CLDI N/A
- Revenue Next Year
- CTXR N/A
- CLDI N/A
- P/E Ratio
- CTXR N/A
- CLDI N/A
- Revenue Growth
- CTXR N/A
- CLDI N/A
- 52 Week Low
- CTXR $0.81
- CLDI $0.35
- 52 Week High
- CTXR $26.25
- CLDI $4.90
- Technical
- Relative Strength Index (RSI)
- CTXR 28.63
- CLDI 38.44
- Support Level
- CTXR $0.81
- CLDI $0.41
- Resistance Level
- CTXR $1.02
- CLDI $0.45
- Average True Range (ATR)
- CTXR 0.09
- CLDI 0.07
- MACD
- CTXR 0.01
- CLDI 0.02
- Stochastic Oscillator
- CTXR 10.09
- CLDI 56.57
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.